Twist Bioscience Corp (TWST): who owns it and who trades it
As of Nov 16, 2026, TWST insiders reported 180 open-market sales worth $148M and no purchases in the last 12 months, with 81% of the sale value made under pre-set 10b5-1 plans. The largest seller was Emily M. Leproust (CEO), with $101M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Twist Bioscience
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns TWST
335 funds and institutions reported TWST shares worth $7.9B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 9.4%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 5.83M | 9.37% | $600M | +5% |
| Artisan Partners Limited Partnership | 4.80M | 7.71% | $494M | -25% |
| FMR LLC (Fidelity) | 4.70M | 7.55% | $484M | +149% |
| ARK Investment Management LLC | 4.55M | 7.31% | $468M | -28% |
| T. Rowe Price Associates | 3.63M | 5.84% | $374M | +5070% |
| State Street Corp | 3.23M | 5.19% | $333M | -12% |
| Vanguard Portfolio Management LLC | 2.82M | 4.54% | $291M | +7% |
| Vanguard Capital Management LLC | 2.70M | 4.33% | $278M | +2% |
| EdgePoint Investment Group Inc. | 2.52M | 4.05% | $259M | -53% |
| William Blair Investment Management, LLC | 2.17M | 3.49% | $224M | -59% |
| Farallon Capital Management, L.l.c. | 2.14M | 3.43% | $220M | +50% |
| Invesco Ltd. | 1.93M | 3.10% | $198M | -11% |
| Geode Capital Management, LLC | 1.62M | 2.60% | $167M | +7% |
| Thrivent Financial for Lutherans | 1.43M | 2.30% | $147M | +9% |
| Goldman Sachs Group Inc | 1.41M | 2.26% | $145M | -17% |
| Morgan Stanley | 1.19M | 1.91% | $122M | +118% |
| D. E. Shaw & Co., Inc. | 1.19M | 1.90% | $122M | +2442% |
| Baillie Gifford & Co | 1.09M | 1.75% | $112M | -11% |
| Driehaus Capital Management LLC | 1.02M | 1.64% | $105M | +75% |
| Sumitomo Mitsui Trust Group, Inc. | 1.00M | 1.61% | $103M | -33% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, TWST insiders reported $0 of open-market purchases and $148M of sales. 81% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 3, 2026 | Dennis Cho | See Remarks | Sale | 949 | $135.40 | $128K | Form 4 |
| Nov 3, 2026 | Patrick John Finn | President | Sale | 2,565 | $135.40 | $347K | Form 4 |
| Nov 3, 2026 | Paula Green | Vice president | Sale | 1,007 | $135.40 | $136K | Form 4 |
| Nov 3, 2026 | Emily M. Leproust | CEO | Sale | 4,573 | $135.40 | $619K | Form 4 |
| Nov 3, 2026 | Robert F. Werner | Chief Accounting Officer | Sale | 148 | $135.40 | $20K | Form 4 |
| Oct 23, 2026 | Patrick John Finn | President | Sale | 2,245 | $134.59 | $302K | Form 4 |
| Oct 9, 2026 | Adam Laponis | CFO | Sale | 2,462 | $156.30 | $385K | Form 4 |
| Oct 5, 2026 | Emily M. Leproust | CEO | Sale plan | 1,840 | $200.44 | $369K | Form 4 |
| Oct 5, 2026 | Emily M. Leproust | CEO | Sale plan | 481 | $201.26 | $96.8K | Form 4 |
| Oct 5, 2026 | Emily M. Leproust | CEO | Sale plan | 1,017 | $202.32 | $206K | Form 4 |
| Oct 5, 2026 | Emily M. Leproust | CEO | Sale plan | 432 | $203.61 | $88K | Form 4 |
| Oct 5, 2026 | Emily M. Leproust | CEO | Sale plan | 290 | $204.80 | $59.4K | Form 4 |
| Oct 5, 2026 | Emily M. Leproust | CEO | Sale plan | 297 | $205.78 | $61.1K | Form 4 |
| Oct 5, 2026 | Emily M. Leproust | CEO | Sale plan | 146 | $206.84 | $30.2K | Form 4 |
| Oct 5, 2026 | Emily M. Leproust | CEO | Sale plan | 45 | $207.46 | $9.3K | Form 4 |
| Oct 2, 2026 | Dennis Cho | See Remarks | Sale | 9,514 | $188.88 | $1.8M | Form 4 |
| Oct 2, 2026 | Patrick John Finn | President | Sale | 25,714 | $188.88 | $4.9M | Form 4 |
| Oct 2, 2026 | Paula Green | Vice president | Sale | 10,088 | $188.88 | $1.9M | Form 4 |
| Oct 2, 2026 | Adam Laponis | CFO | Sale | 8,057 | $188.88 | $1.5M | Form 4 |
| Oct 2, 2026 | Emily M. Leproust | CEO | Sale plan | 45,736 | $188.88 | $8.6M | Form 4 |
| Oct 2, 2026 | Robert F. Werner | Chief Accounting Officer | Sale | 1,482 | $188.88 | $280K | Form 4 |
| Oct 1, 2026 | Emily M. Leproust | CEO | Sale plan | 655 | $200.00 | $131K | Form 4 |
| Sep 24, 2026 | Emily M. Leproust | CEO | Sale plan | 16 | $182.50 | $2.9K | Form 4 |
| Sep 24, 2026 | Emily M. Leproust | CEO | Sale plan | 501 | $183.76 | $92.1K | Form 4 |
| Sep 24, 2026 | Emily M. Leproust | CEO | Sale plan | 21 | $181.45 | $3.8K | Form 4 |
| Sep 24, 2026 | Emily M. Leproust | CEO | Sale plan | 515 | $180.39 | $92.9K | Form 4 |
| Sep 24, 2026 | Emily M. Leproust | CEO | Sale plan | 143 | $179.93 | $25.7K | Form 4 |
| Sep 24, 2026 | Emily M. Leproust | CEO | Sale plan | 330 | $178.67 | $59K | Form 4 |
| Sep 24, 2026 | Emily M. Leproust | CEO | Sale plan | 164 | $177.17 | $29.1K | Form 4 |
| Sep 24, 2026 | Emily M. Leproust | CEO | Sale plan | 945 | $176.39 | $167K | Form 4 |
| Sep 24, 2026 | Emily M. Leproust | CEO | Sale plan | 2,485 | $175.23 | $435K | Form 4 |
| Sep 24, 2026 | Emily M. Leproust | CEO | Sale plan | 83 | $184.60 | $15.3K | Form 4 |
| Sep 21, 2026 | Dennis Cho | See Remarks | Sale | 348 | $165.49 | $57.6K | Form 4 |
| Sep 21, 2026 | Paula Green | Vice president | Sale | 294 | $165.49 | $48.7K | Form 4 |
| Sep 21, 2026 | Emily M. Leproust | CEO | Sale | 1,687 | $165.49 | $279K | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 4,175 | $154.17 | $644K | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 2,565 | $162.31 | $416K | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 11,169 | $161.49 | $1.8M | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 2,440 | $151.46 | $370K | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 6,644 | $152.21 | $1M | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 3,399 | $153.40 | $521K | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 869 | $163.39 | $142K | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 13,378 | $155.46 | $2.1M | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 9,097 | $156.47 | $1.4M | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 32,260 | $157.49 | $5.1M | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 232,173 | $158.09 | $36.7M | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 23,884 | $159.53 | $3.8M | Form 4 |
| Sep 17, 2026 | Emily M. Leproust | CEO | Sale plan | 14,493 | $160.44 | $2.3M | Form 4 |
| Sep 8, 2026 | Dennis Cho | See Remarks | Sale | 412 | $122.62 | $50.5K | Form 4 |
| Sep 8, 2026 | Paula Green | Vice president | Sale | 907 | $122.62 | $111K | Form 4 |
| Sep 8, 2026 | Emily M. Leproust | CEO | Sale | 2,302 | $122.62 | $282K | Form 4 |
| Sep 8, 2026 | Robert F. Werner | Chief Accounting Officer | Sale | 238 | $122.62 | $29.2K | Form 4 |
| Aug 25, 2026 | Emily M. Leproust | CEO | Sale plan | 9,181 | $153.93 | $1.4M | Form 4 |
| Aug 25, 2026 | Emily M. Leproust | CEO | Sale plan | 6,412 | $152.75 | $979K | Form 4 |
| Aug 25, 2026 | Emily M. Leproust | CEO | Sale plan | 12,236 | $151.36 | $1.9M | Form 4 |
| Aug 25, 2026 | Emily M. Leproust | CEO | Sale plan | 12,648 | $150.56 | $1.9M | Form 4 |
| Aug 25, 2026 | Emily M. Leproust | CEO | Sale plan | 1,093 | $154.45 | $169K | Form 4 |
| Aug 24, 2026 | Robert F. Werner | Chief Accounting Officer | Sale | 854 | $140.77 | $120K | Form 4 |
| Aug 21, 2026 | Dennis Cho | See Remarks | Sale | 1,598 | $139.07 | $222K | Form 4 |
| Aug 21, 2026 | Patrick John Finn | President | Sale | 4,046 | $139.07 | $563K | Form 4 |
| Aug 21, 2026 | Paula Green | Vice president | Sale | 1,360 | $139.07 | $189K | Form 4 |
| Aug 21, 2026 | Adam Laponis | CFO | Sale | 1,965 | $139.07 | $273K | Form 4 |
| Aug 21, 2026 | Emily M. Leproust | CEO | Sale | 6,639 | $139.07 | $923K | Form 4 |
| Aug 21, 2026 | Robert F. Werner | Chief Accounting Officer | Sale | 669 | $139.07 | $93K | Form 4 |
| Aug 19, 2026 | Dennis Cho | See Remarks | Sale plan | 14,205 | $129.75 | $1.8M | Form 4 |
| Aug 18, 2026 | Patrick John Finn | President | Sale plan | 2,000 | $122.58 | $245K | Form 4 |
| Aug 18, 2026 | Patrick John Finn | President | Sale plan | 6,296 | $121.01 | $762K | Form 4 |
| Aug 18, 2026 | Patrick John Finn | President | Sale plan | 12,917 | $119.86 | $1.5M | Form 4 |
| Aug 18, 2026 | Patrick John Finn | President | Sale plan | 4,500 | $119.04 | $536K | Form 4 |
| Aug 18, 2026 | Patrick John Finn | President | Sale plan | 8,868 | $117.70 | $1M | Form 4 |
| Aug 18, 2026 | Patrick John Finn | President | Sale plan | 10,420 | $116.82 | $1.2M | Form 4 |
| Aug 18, 2026 | Patrick John Finn | President | Sale plan | 33,354 | $115.90 | $3.9M | Form 4 |
| Aug 12, 2026 | Katryn Blake | Director | Sale | 2,240 | $122.88 | $275K | Form 4 |
| Aug 12, 2026 | Emily M. Leproust | CEO | Sale plan | 19,952 | $125.08 | $2.5M | Form 4 |
| Aug 10, 2026 | Emily M. Leproust | CEO | Sale plan | 113,318 | $125.16 | $14.2M | Form 4 |
| Aug 7, 2026 | Robert Chess | Director | Sale plan | 18,417 | $110.89 | $2M | Form 4 |
| Aug 5, 2026 | Dennis Cho | See Remarks | Sale plan | 14,205 | $109.75 | $1.6M | Form 4 |
| Aug 3, 2026 | Patrick John Finn | President | Sale | 2,888 | $85.32 | $246K | Form 4 |
| Aug 3, 2026 | Paula Green | Vice president | Sale | 1,133 | $85.32 | $96.7K | Form 4 |
| Aug 3, 2026 | Emily M. Leproust | CEO | Sale | 5,101 | $85.32 | $435K | Form 4 |
| Aug 3, 2026 | Robert F. Werner | Chief Accounting Officer | Sale | 167 | $85.32 | $14.2K | Form 4 |
| Aug 3, 2026 | Dennis Cho | See Remarks | Sale | 1,070 | $85.32 | $91.3K | Form 4 |
| Jul 23, 2026 | Patrick John Finn | President | Sale | 2,238 | $93.89 | $210K | Form 4 |
| Jul 9, 2026 | Adam Laponis | CFO | Sale | 2,399 | $94.33 | $226K | Form 4 |
| Jun 25, 2026 | Emily M. Leproust | CEO | Sale plan | 18,880 | $95.00 | $1.8M | Form 4 |
| Jun 24, 2026 | Dennis Cho | See Remarks | Sale plan | 14,205 | $89.75 | $1.3M | Form 4 |
| Jun 22, 2026 | Paula Green | Vice president | Sale | 291 | $87.32 | $25.4K | Form 4 |
| Jun 22, 2026 | Dennis Cho | See Remarks | Sale | 346 | $87.32 | $30.2K | Form 4 |
| Jun 22, 2026 | Emily M. Leproust | CEO | Sale | 1,688 | $87.32 | $147K | Form 4 |
| Jun 15, 2026 | Paula Green | Vice president | Sale | 2,028 | $82.17 | $167K | Form 4 |
| Jun 15, 2026 | Paula Green | Vice president | Sale | 24,109 | $81.62 | $2M | Form 4 |
| Jun 8, 2026 | Dennis Cho | See Remarks | Sale | 402 | $69.84 | $28.1K | Form 4 |
| Jun 8, 2026 | Paula Green | Vice president | Sale | 884 | $69.84 | $61.7K | Form 4 |
| Jun 8, 2026 | Emily M. Leproust | CEO | Sale | 2,265 | $69.84 | $158K | Form 4 |
| Jun 8, 2026 | Robert F. Werner | Chief Accounting Officer | Sale | 1,127 | $69.07 | $77.8K | Form 4 |
| Jun 8, 2026 | Robert F. Werner | Chief Accounting Officer | Sale | 232 | $69.84 | $16.2K | Form 4 |
| May 29, 2026 | Dennis Cho | See Remarks | Sale plan | 14,205 | $69.75 | $991K | Form 4 |
| May 29, 2026 | Adam Laponis | CFO | Sale plan | 4,000 | $70.00 | $280K | Form 4 |
| May 28, 2026 | Emily M. Leproust | CEO | Sale plan | 900 | $66.85 | $60.2K | Form 4 |
| May 28, 2026 | Emily M. Leproust | CEO | Sale plan | 1,482 | $65.33 | $96.8K | Form 4 |
Latest 100 of 180 trades in the last 12 months.
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Emily M. Leproust | Chief Executive Officer, Director | – | $101M | Nov 3, 2026 |
| Patrick John Finn | President and COO | – | $21.5M | Nov 3, 2026 |
| Dennis Cho | See Remarks | – | $8.7M | Nov 3, 2026 |
| Paula Green | SVP of Human Resources | – | $7.1M | Nov 3, 2026 |
| Adam Laponis | Chief Financial Officer | – | $4M | Oct 9, 2026 |
| Robert Chess | Director | – | $2.6M | Aug 7, 2026 |
| Robert F. Werner | Chief Accounting Officer | – | $1.5M | Nov 3, 2026 |
| Jan Johannessen | Director | – | $953K | May 12, 2026 |
| Melissa A. Starovasnik | Director | – | $282K | May 28, 2026 |
| Katryn Blake | Director | – | $275K | Aug 12, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
TWST short interest
High short interest. 15.7% of TWST shares are sold short: about 1 share in 6. Over the last 12 reports the number of shares short went down 41%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 9.84M TWST shares were sold short, 15.7% of the shares outstanding, down 3.6% from the report before. At the average daily volume of 2.26M shares, buying them all back would take about 4.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 9.84M | 15.69% | -4% | 2.26M | 4.3 |
| Oct 15, 2026 | 10.21M | 16.28% | -3% | 3.62M | 2.8 |
| Sep 30, 2026 | 10.57M | 16.85% | -15% | 2.76M | 3.8 |
| Sep 15, 2026 | 12.51M | 19.94% | +4% | 1.40M | 8.9 |
| Aug 31, 2026 | 12.07M | 19.24% | -14% | 1.75M | 6.9 |
| Aug 14, 2026 | 14.11M | 22.50% | +0% | 1.78M | 7.9 |
| Jul 31, 2026 | 14.08M | 22.45% | -0% | 1.27M | 11.1 |
| Jul 15, 2026 | 14.12M | 22.67% | +1% | 1.46M | 9.7 |
| Jun 30, 2026 | 13.95M | 22.40% | -21% | 2.53M | 5.5 |
| Jun 15, 2026 | 17.66M | 28.36% | +19% | 1.84M | 9.6 |
| May 29, 2026 | 14.90M | 23.93% | -10% | 1.66M | 9.0 |
| May 15, 2026 | 16.58M | 26.62% | +19% | 1.59M | 10.4 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Twist Bioscience company events
Twist Bioscience filed 9 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Aug 19, 2026.
- Aug 19, 2026AnnouncementPursuant to that certain Registration Rights Agreement dated February 11, 2026 by and between Twist Bioscience Corporation and Invenra Inc., the Company is filing a prospectus supplement to register the resale of shares issuable pursuant to that certain Stock Purchase Agreement dated February 11… Filing
- Aug 19, 2026AnnouncementShared information with investors. Filing
- Aug 5, 2026AgreementTwist Bioscience Corporation entered into an underwriting agreement with Goldman Sachs & Co. LLC, William Blair & Company, L.L.C., Leerink Partners LLC, and Guggenheim Securities, LLC, as representatives of the several underwriters named therein, pursuant to which the Company agreed to issue and… Filing
- Aug 3, 2026ResultsReleased financial results. Filing
- May 4, 2026ResultsReleased financial results. Filing
- Feb 17, 2026AnnouncementIs incorporated into this Item 3.02 by reference. Filing
- Feb 6, 2026VoteReported shareholder vote results. Filing
- Feb 2, 2026ResultsReleased financial results. Filing
- Jan 12, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Twist Bioscience financials
Famous investors that hold TWST
4 of the 50 well-known investors we track reported holding TWST in their latest 13F filing. The largest position is Cathie Wood's, worth $657M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Cathie Wood · ARK Investment Management | Q3 2026 | 3.40M | $657M | 3.8% | -25% |
| Israel Englander · Millennium Management | Q3 2026 | 495,312 | $95.7M | 0.1% | +43% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 343,262 | $66.3M | 0.1% | New |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 83,029 | $16M | 0.1% | +345% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 8 filings named TWST in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 16, 2026 | T. Rowe Price Associates, Inc. | 13G/A | 9.2% |
| Nov 16, 2026 | T. Rowe Price Associates, Inc. | 13G/A | 9.2% |
| Nov 12, 2026 | Artisan Partners Asset Management Inc. | 13G/A | 3.4% |
| Nov 12, 2026 | Artisan Partners Asset Management Inc. | 13G/A | 3.4% |
| Nov 10, 2026 | STATE STREET CORPORATION | 13G | 4.6% |
| Nov 10, 2026 | STATE STREET CORPORATION | 13G | 4.6% |
| Nov 5, 2026 | FMR LLC | 13G/A | 14.4% |
| Nov 5, 2026 | FMR LLC | 13G/A | 14.4% |
Questions about Twist Bioscience Corp (TWST) stock
Who owns the most TWST stock?
The largest reported owner of Twist Bioscience Corp (TWST) is BlackRock, Inc., with 9.4% of the company. In total, 335 funds and institutions reported holding TWST at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are TWST insiders buying or selling?
In the last 12 months, TWST insiders reported no open-market purchases and 180 sales worth $148M. The latest trade was on Nov 3, 2026. See every trade.
What is the short interest in TWST?
As of Oct 30, 2026, 9.84M TWST shares were sold short, 15.7% of the shares outstanding, down 3.6% from the report before. At the average daily volume of 2.26M shares, buying them all back would take about 4.3 trading days (days to cover). See the history.
Which famous investors hold TWST?
4 of the 50 well-known investors we track reported TWST in their latest 13F filing, including Cathie Wood, Israel Englander, Steve Cohen. The largest position is worth $657M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.